Search
Close this search box.

News Updates

Day: August 11, 2023

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Hayward Holdings, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – HAYW

NEW YORK, Aug. 10, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hayward Holdings, Inc. (NYSE: HAYW) between March 2, 2022 and July 27, 2022, both dates inclusive (the “Class Period”), of the important October 2, 2023 lead

Continue Reading...

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages BioXcel Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BTAI

NEW YORK, Aug. 11, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioXcel Therapeutics, Inc. (NASDAQ: BTAI) between December 15, 2021 and June 28, 2023, both dates inclusive (the “Class Period”), of the important September 5, 2023 lead plaintiff

Continue Reading...

SE SHAREHOLDER ALERT: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Sea Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – SE

NEW YORK, Aug. 10, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sea Limited (NYSE: SE) between April 23, 2022 and May 15, 2023, both dates inclusive (the “Class Period”), of the important September 19, 2023 lead plaintiff deadline.

Continue Reading...

ROSEN, A LONGSTANDING LAW FIRM, Encourages Eos Energy Enterprises, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EOSE, EOSEW

NEW YORK, Aug. 10, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Eos Energy Enterprises, Inc. (NASDAQ: EOSE, EOSEW) between May 9, 2022 and July 27, 2023, both dates inclusive (the “Class Period”), of the important October 2, 2023

Continue Reading...

ROSEN, A RANKED AND LEADING FIRM, Encourages Apellis Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – APLS

NEW YORK, Aug. 10, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) between January 28, 2021 and July 28, 2023, both dates inclusive

Continue Reading...